abstract |
The present invention is directed to a method of determining the intensity of pain in a patient, a diagnostic kit for determining the intensity of pain in a patient and a pharmaceutical composition for use in the treatment of pain. Further, the present invention is concerned with the use of the proteins IL-7, IL-18, MCP-1, MIP-1b and OPG as biomarkers for pain intensity. |